Sun Pharmaceutical Industries Inc. Issues Voluntary Nationwide Recall of Riomet® (Metformin Hydrochloride Oral Solution) Manufactured by a Contract Manufacturer due to Microbial Contamination

Sun Pharmaceutical Industries Inc. Issues Voluntary Nationwide Recall of Riomet® (Metformin Hydrochloride Oral Solution) Manufactured by a Contract Manufacturer due to Microbial Contamination

Sun Pharmaceutical Industries Inc. Issues Voluntary Nationwide Recall of Riomet® (Metformin Hydrochloride Oral Solution) Manufactured by a Contract Manufacturer due to Microbial Contamination

Sun Pharmaceutical Industries Inc. Issues Voluntary Nationwide Recall of Riomet® (Metformin Hydrochloride Oral Solution) Manufactured by a Contract Manufacturer due to Microbial Contamination

Recalls, Market Withdrawals, & Safety Alerts > Sun Pharmaceutical Industries Inc. Issues Voluntary Nationwide Recall of Riomet® (Metformin Hydrochloride Oral Solution) Manufactured by a Contract Manufacturer due to Microbial Contamination

Recalls, Market Withdrawals, & Safety Alerts > Sun Pharmaceutical Industries Inc. Issues Voluntary Nationwide Recall of Riomet® (Metformin Hydrochloride Oral Solution) Manufactured by a Contract Manufacturer due to Microbial Contamination

AstraZeneca Pharma India and Sun Pharmaceutical Industries today said they have entered into a distribution services agreement for AstraZeneca’s brand Axcer, a new brand of ticagrelor, in India. - See more at: http://ways2capital-equitytips.blogspot.in/2015/06/sun-pharma-astrazeneca-in-distribution.html#sthash.Wg2ewbNP.dpuf

AstraZeneca Pharma India and Sun Pharmaceutical Industries today said they have entered into a distribution services agreement for AstraZeneca’s brand Axcer, a new brand of ticagrelor, in India.

Sun Pharmaceutical Industries Ltd has completed the acquisition of 85.1% of Jio Biosintez, a Russian

Sun Pharmaceutical Industries (Sun Pharma) has received the order passed by National Company Law Tribunal (NCLT) at Ahmedabad bench in the matter of Scheme

Sun Pharmaceuticals Becomes Asia's Largest Pharmaceutical Company   #Pharmaceutical #AsianMarket #SunPharmaceuticals #AsiaOne #AsiaOneNews #AsiaOneMagazine #AsiaNews

Sun Pharmaceuticals Becomes Asia's Largest Pharmaceutical Company #Pharmaceutical #AsianMarket #SunPharmaceuticals #AsiaOne #AsiaOneNews #AsiaOneMagazine #AsiaNews

Shares of Sun Pharmaceutical Industries gained more than 1 percent Tuesday on completion of acquisition of Opiates business in Australia. - See more at: http://ways2capital-equitytips.blogspot.in/2015/09/sun-pharma-up-1-completes-acquisition.html#sthash.ns0cKyxJ.dpuf

Drug major Sun Pharmaceutical Industries on Wednesday said it has received approval from the US health regulator for its new drug application for acne treatment medicine--XiminoTM extended-release capsules.

Sun Pharmaceutical Industries Ltd announced that one of its subsidiaries has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Gleevec , Imatinib Mesylate tablets 100mg and 400mg Imatinib Mesylate tablets,

Sun Pharmaceutical Industries Ltd announced that one of its subsidiaries has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Gleevec , Imatinib Mesylate tablets and Imatinib Mesylate tablets,

As part of its business strategy to build a meaningful & differentiating presence in Global Oncology Therapy market, Sun Pharma,

Sun Pharmaceutical Industries Ltd’s southward journey continues for yet another trading session. The scrip is currently trading lower at Rs. on BSE, which is a low level.

Sun Pharmaceutical Industries Ltd. has recalled 68,000 bottles of the antidepressant Effexor in the U.S., in the second recall of the drug this year, the U.S. Food and Drug Administration said http://online.wsj.com/articles/sun-pharma-recalls-effexor-in-u-s-1416297616?mod=WSJ_LatestHeadlines

Sun Pharma Recalls Effexor in U.S.

A man carrying a gas cylinder walks out of the research and development centre of Sun Pharmaceutical Industries in Mumbai.

India’s largest drugmaker Sun Pharmaceutical Industries Ltd said it had received a warning letter from the US Food and Drug Administration for violating manufacturing standards at its Halol plant in western India. The warning indicates the agency is not satisfied with the remedial measures Sun Pharma has been taking at the plant since last September …

Sun Pharma Announces US FDA Filing Acceptance of Biologics License Application (BLA) For Tildrakizumab

"Global Oxcarbazepine (CAS 28721-07-5) Market 2016 – Novartis, Taj Pharmaceuticals, Euticals, CTX Lifesciences, Sun Pharmaceutical, Jubilant, Zhejiang Jiuzhou, Langfang Gaobo, Hubei Gedian Humanwell" published by "theneighborhooduk" on @edocr

edocr is the only document marketplace to facilitate free lead generation, SEO visibility, and document selling.

Infografik Dilip Shanghvi: Geschäftsführer des indischen Sun Pharmaceuticals, dem größten Farma-Unternehmen in Indien und dem fünftgrößten weltweit.

Infografik Dilip Shanghvi: Geschäftsführer des indischen Sun Pharmaceuticals, dem größten Farma-Unternehmen in Indien und dem fünftgrößten weltweit.

Shares of Sun Pharmaceutical are currently trading 0.52% higher at Rs. 816 on BSE after the company yesterday received USFDA nod for BromSite.

Shares of Sun Pharmaceutical are currently trading higher at Rs. 816 on BSE after the company yesterday received USFDA nod for BromSite.

21. Sun Pharmaceutical

The 21 biggest family-owned businesses in the world

Pinterest
Search